Valuation Kintor Pharmaceutical Limited OTC Markets
Stocks
KNTPF
KYG5273B1077
Biotechnology & Medical Research
|
Market Closed -
OTC Markets
21:30:02 16/09/2026 HKT
|
5-day change | 1st Jan Change | ||
| 0.2415 USD | +0.62% |
|
-.--% | +11.81% |
Company Valuation: Kintor Pharmaceutical Limited
Data adjusted to current consolidation scope
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 3,253 | 3,884 | 3,899 | 662.1 | 394.7 | 869.2 |
| Change | - | 19.37% | 0.39% | -83.02% | -40.39% | 120.26% |
| Enterprise Value (EV) 1 | 2,082 | 2,987 | 3,308 | 458 | 379 | 923.1 |
| Change | - | 43.46% | 10.77% | -86.16% | -17.25% | 143.58% |
| P/E | -5.36x | -4.24x | -3.44x | -0.6x | -2.53x | -3.96x |
| PBR | 2.16x | 2.35x | 2.61x | 1.42x | 1.35x | 4.76x |
| PEG | - | -0.1x | -0.47x | 0.25x | 0x | -0.2x |
| Capitalization / Revenue | - | 113,459,524x | - | - | 78,930,130x | 26,597,148x |
| EV / Revenue | - | - | - | - | - | - |
| EV / EBITDA | -5.54x | -3.61x | -3.46x | -0.43x | -2.95x | -6.55x |
| EV / EBIT | -5.49x | -3.58x | -3.41x | -0.43x | -2.67x | -5.35x |
| EV / FCF | -6.9x | -3.34x | -4.85x | -3.82x | -2.73x | -12.9x |
| FCF Yield | -14.5% | -30% | -20.6% | -26.2% | -36.6% | -7.77% |
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | -1.643 | -2.363 | -2.534 | -2.472 | -0.3605 | -0.4449 |
| Distribution rate | - | - | - | - | - | - |
| Net sales | - | 34.23 | - | - | 5 | 32.68 |
| EBITDA 1 | -375.6 | -828 | -956.4 | -1,056 | -128.6 | -140.9 |
| EBIT 1 | -379 | -834.7 | -969.1 | -1,070 | -141.8 | -172.5 |
| Net income 1 | -508.3 | -842.1 | -954.4 | -1,061 | -155.3 | -200.1 |
| Net Debt 1 | -1,171 | -897 | -590.6 | -204.1 | -15.68 | 53.86 |
| Reference price 2 | 8.808 | 10.020 | 8.713 | 1.480 | 0.912 | 1.761 |
| Nbr of stocks (in thousands) | 369,390 | 387,590 | 447,500 | 447,500 | 432,965 | 493,525 |
| Announcement Date | 29/4/21 | 27/4/22 | 28/4/23 | 29/4/24 | 29/4/25 | 29/4/26 |
1CNY in Million2CNY
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 21.73x | 7.71x | 15.48x | 1.37% | 74.16B | |
| 29.82x | 8.57x | 26.7x | 0.04% | 57.39B | |
| 32.98x | 5.93x | 17.77x | 0.98% | 47.64B | |
| -21.31x | 230.81x | -22.97x | -.--% | 44.29B | |
| 33.26x | 3.23x | 13.97x | -.--% | 42.5B | |
| 46.77x | 5.41x | 29.66x | -.--% | 40.71B | |
| 27.63x | 7.93x | 20.48x | 0.41% | 30.97B | |
| 32.99x | 7.05x | 18.3x | -.--% | 28.53B | |
| -15.1x | 5.68x | -7.14x | -.--% | 24.34B | |
| Average | 20.98x | 31.37x | 12.47x | 0.31% | 43.39B | |
| Weighted average by Cap. | 22.27x | 32.04x | 13.55x | 0.42% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- 9939 Stock
- KNTPF Stock
- Valuation Kintor Pharmaceutical Limited
Select your edition
All financial news and data tailored to specific country editions
